This inventor holds 17 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Electron Beam Technology. Top assignees: Adv Antest Corporation, Chiba University, Genedesign, Inc.. Active years: 2002-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2002 - 2020)
- Chiba, JP (2022)
Company Filing History:
12 out of 2,283 
2 out of 156 
2 out of 5 
Years Active: 2002-2022
Areas of Expertise:
Title: Innovations in Cancer Treatment by Inventor Takeshi Haraguchi
Introduction
Takeshi Haraguchi is a notable inventor based in Tokyo, Japan, recognized for his groundbreaking work in oncology. With a prolific portfolio comprising 17 patents, Haraguchi has made significant contributions toward developing innovative treatments for cancer, showcasing his dedication to medical advancement.
Latest Patents
Among Haraguchi's latest patents is a revolutionary technique for treating cancer, utilizing a structurally-reinforced S-TuD. This novel approach presents a composition aimed at the prevention or treatment of tumors, featuring an miRNA inhibitory complex that includes RNA or its analogs. The complexity of the invention is evident, as it involves a method for delivering this miRNA inhibitory complex, ideally through a double-stranded structure, which enhances the effectiveness of tumor suppression.
Additionally, Haraguchi developed a method for suppressing tumors by inhibiting the miR-200 family. His research revealed that tumor growth was substantially suppressed in vivo by inhibiting specific miRNA sequences, which not only altered the tumor cell population but also demonstrated a remarkable capacity for shrinking existing tumors. This innovation holds great therapeutic potential against various tumor types.
Career Highlights
Throughout his career, Takeshi Haraguchi has worked with prestigious institutions and companies, including Adv Antest Corporation and the University of Tokyo. His work in these organizations has allowed him to push the boundaries of cancer research and develop impactful solutions for patients.
Collaborations
Haraguchi has collaborated with eminent colleagues such as Hiroshi Yasuda and Yoshihisa Ooae. Together, they have driven significant advancements in cancer treatment, leveraging their collective expertise to enhance patient outcomes in oncology.
Conclusion
Takeshi Haraguchi's contributions to cancer treatment exemplify the powerful intersection of innovation and medical science. His patented techniques not only highlight his skills as an inventor but also reflect a commitment to improving healthcare through advanced therapeutic solutions. As research continues to evolve, Haraguchi’s innovations are anticipated to play a crucial role in future cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile